Nasal vaccines offer non-invasive alternate to traditional intramuscular or intravenous vaccines. Nasal vaccines mimic the natural route of infection, thereby inducing mucosal as well as systemic immune responses. This leads to the production of sIgA at mucosal surfaces like inner lining of nose and lungs that provides first line of defense against respiratory infections.

The global Nasal Vaccines Market is estimated to be valued at US$ 416.8 Mn in 2023 and is expected to ... Read more

Nasal vaccines are administered through nostrils and provide improved immunogenicity and stimulation of immune response at the site of infection. Nasal vaccines are needle-free and induce both mucosal and systemic immunity. They avoid pain and trauma associated with intramuscular injections and are better for immunizing mass population. Nasal vaccines offer an improvement over injectable vaccines as they elicit a comprehensive immune response at the entry points of various pathogens. The ... Read more